Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating Activities:    
Consolidated net loss $ (23,964) $ (11,658)
Adjustments to reconcile consolidated net loss to net cash provided by operating activities:    
Depreciation and amortization of intangibles 28,486 26,526
Interest expense added to term debt 0 9,451
Fair value adjustments (473) 53
Amortization of debt discount 454 930
Amortization of deferred financing fees 339 97
Non-cash compensation 2,985 1,888
Loss (gain) on derivative instruments 836 (1,669)
Bad debt expense 4 325
Changes in operating assets and liabilities, net of effects from acquisition of ICP:    
Accounts receivable 25,625 (7,803)
Inventories (1,891) (4,168)
Prepaid expenses and other assets 2,197 5,503
Prepaid inventory 4,397 (1,657)
Accounts payable and accrued expenses (3,995) (2,789)
Net cash provided by operating activities 35,000 15,029
Investing Activities:    
Additions to property and equipment (12,348) (14,045)
Purchase of ICP, net of cash acquired (28,921) 0
Proceeds from cash collateralized letters of credit 0 4,113
Net cash used in investing activities (41,269) (9,932)
Financing Activities:    
Net (payments) proceeds from Kinergy’s line of credit (5,889) 2,913
Proceeds from ICP credit facilities 42,000 0
Proceeds from assessment financing 1,144 1,020
Net proceeds from notes 13,530 0
Payments for debt issuance costs (924) 0
Principal payments on borrowings (54,927) (17,003)
Payments on capital leases (588) (3,151)
Proceeds from exercise of warrants and options 1,202 0
Preferred stock dividends paid (946) (949)
Net cash used in financing activities (5,398) (17,170)
Net decrease in cash and cash equivalents (11,667) (12,073)
Cash and cash equivalents at beginning of period 68,590 52,712
Cash and cash equivalents at end of period 56,923 40,639
Supplemental Information:    
Interest paid 8,291 7,256
Income taxes received 5,601 4,784
Noncash financing and investing activities:    
Issuance of notes payable for acquisition of ICP 46,927 0
Reclass of warrant liability to equity upon warrant exercises $ 178 $ 0